Keywords: phytopharm, new, obesity, drug, deal, pfizer, uk-based

Phytopharm new obesity drug deal with Pfizer

Article | 05 August 2002

Print This

UK-based Phytopharm has reached a new deal with Pfizer on thedevelopment of its cactus-derived antiobesity drug P57. The drug is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in